Sara Kalantari to Treatment Outcome
This is a "connection" page, showing publications Sara Kalantari has written about Treatment Outcome.
Connection Strength
0.168
-
Galectin-3 as a Prognostic Biomarker of Left Ventricular Assist Device Implantation Outcomes. ASAIO J. 2025 Feb 01; 71(2):136-142.
Score: 0.024
-
Clinical outcomes of grafted vs. percutaneous axillary intra-aortic balloon pump support as a bridge to transplantation: a propensity score-matched analysis. Heart Vessels. 2022 Dec; 37(12):1995-2001.
Score: 0.021
-
Significant vascular complications in percutaneous axillary intra-aortic balloon pump. Ann Vasc Surg. 2022 Jul; 83:42-52.
Score: 0.020
-
Increased Rate of Pump Thrombosis and Cardioembolic Events Following Ventricular Tachycardia Ablation in Patients Supported With Left Ventricular Assist Devices. ASAIO J. 2020 Nov/Dec; 66(10):1127-1136.
Score: 0.018
-
Decoupling Between Diastolic Pulmonary Artery and Pulmonary Capillary Wedge Pressures Is Associated With Right Ventricular Dysfunction and Hemocompatibility-Related Adverse Events in Patients With Left Ventricular Assist Devices. J Am Heart Assoc. 2020 04 07; 9(7):e014801.
Score: 0.018
-
Effect of Concomitant Tricuspid Valve Surgery With Left Ventricular Assist Device Implantation. Ann Thorac Surg. 2020 09; 110(3):918-924.
Score: 0.017
-
Metabolic Dysfunction in Continuous-Flow Left Ventricular Assist Devices Patients and Outcomes. J Am Heart Assoc. 2019 11 19; 8(22):e013278.
Score: 0.017
-
Echocardiographic evaluation of the effects of sacubitril-valsartan on vascular properties in heart failure patients. Int J Cardiovasc Imaging. 2020 Feb; 36(2):271-278.
Score: 0.017
-
Omega-3 Therapy Is Associated With Reduced Gastrointestinal Bleeding in Patients With Continuous-Flow Left Ventricular Assist Device. Circ Heart Fail. 2018 10; 11(10):e005082.
Score: 0.016